Company / Total Debt
Emergent BioSolutions Inc. Total Debt History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$589.7M
FY2025
5-year range
$589.7M / $1.4B
FY2021-FY2025
Trend
-15.8%
vs FY2024
Sector context
#28 of 83
Health Care
What the data says
At $590M, Emergent BioSolutions Inc.'s total debt ranks #56 of 83 in the Health Care sector. Total Debt has declined for 3 consecutive years, from $1.4B in FY2022 to $590M in FY2025.
Based on SEC 10-K filings.
$590M in FY2025 with a 5-year CAGR of -7.8%.
Improved from $868M to $590M over the past 2 years.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- -25.3%
- 5-Year CAGR
- -7.8%
- 10-Year CAGR
- -
Sector benchmark
#56 of 83 in Health CareTop 66% of 83This company $589.7M Sector average $6.2B
▼
-90.4% below sector average
Key checks
Key Insights
- Emergent BioSolutions Inc.'s total debt has declined for 3 consecutive years.
- 5-year CAGR of -7.8%, indicating a declining trend.
- In FY2025, total debt decreased 15.8% year-over-year.
- Ranks #28 out of 83 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $589.7M | -15.8% |
| FY2024 | $700.0M | -19.4% |
| FY2023 | $868.4M | -38.6% |
| FY2022 | $1.4B | +66.4% |
| FY2021 | $849.6M | -4.1% |
| FY2020 | $885.5M | +7.7% |
| FY2019 | $822.5M | +1.7% |
| FY2018 | $808.8M | +5847.1% |
| FY2017 | $13.6M | -94.5% |
| FY2016 | $248.1M | +0.5% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026